skip to Main Content

Emmes Acquires UK-Based Orphan Reach

Second Add-on Acquisition Under Behrman’s Ownership Further Expands Emmes’ European Footprint and Market-Leading Capabilities in Rare Diseases Rockville, MD, May 11, 2021 – Emmes (the “Company”), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public…

Read More

Emmes Acquires Neox

Transaction Expands Emmes’ BioPharma Effort and European Presence Rockville, MD – December 30, 2020 – The Emmes Company, LLC (“Emmes”), a full-service clinical research organization (CRO) dedicated to supporting the advancement of human health and biopharmaceutical innovation and a portfolio…

Read More

Behrman Capital Invests in Emmes

New York, March 11, 2019 – Behrman Capital (“Behrman”), a private equity investment firm based in New York and San Francisco, today announced that it has made a significant investment in The Emmes Corporation (“Emmes” or “the Company”). Financial terms…

Read More
Back To Top